COMMUNIQUÉS West-GlobeNewswire

Ossur Hf : Updated financial calendar for the financial year 2018

25/04/2018 - 22:03

Announcement no. 32/2018 25 April 2018 Updated financial calendar for the financial year 2018 Compared with the previously announced financial calendar, company announcement no. 87/2017, 13 December 2017, Össur has [...]

Calithera Biosciences Announces CB-839 Abstracts Accepted for Presentation at ASCO 2018

25/04/2018 - 22:03

SOUTH SAN FRANCISCO, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA ), a clinical stage biotechnology company focused on the development of novel cancer therapeutics, today [...]

Galapagos reports first quarter 2018 results

25/04/2018 - 22:02

Key Q1 2018 results: Group revenues of €44.8 million Operating loss €32.0 million Net loss of €37.3 million End of first quarter cash and cash equivalents €1.1 billion Clinical progress reported in CF and OA, [...]

Ossur Hf : Interim report Q1 2018

25/04/2018 - 22:01

Announcement no. 31/2018 Interim report Q1 2018 25 April 2018 Highlights Q1 2018 Sales amounted to USD 142 million, corresponding to 8% USD growth and 1% organic growth. The prosthetics segment grew 4% while sales of B [...]

Merit Medical Reports Record Revenues for First Quarter of 2018

25/04/2018 - 22:01

Q1 2018 worldwide revenue of $203.0 million ($197.9 million on a comparable, constant currency* basis), up 18.7% as reported (up 15.7% on a comparable, constant currency* basis) over Q1 2017 Q1 2018 core revenue* up 10. [...]

Xenon Pharmaceuticals to Present at the 2018 Bloom Burton & Co. Healthcare Investor Conference

25/04/2018 - 22:01

BURNABY, British Columbia, April 25, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE ), a clinical-stage biopharmaceutical company, today announced that Dr. Simon Pimstone, Xenon's Chief Executive [...]

PRA Health Sciences, Inc. Reports First Quarter 2018 Results

25/04/2018 - 22:00

Net new business of $650.3 million; Net book-to-bill of 1.29 $701.8 million of revenue in the first quarter; 43.9% growth at actual foreign exchange rates and 40.7% growth on a constant currency basis compared to the [...]

Align Technology Announces First Quarter 2018 Financial Results

25/04/2018 - 22:00

Q1 revenues up 40.8% year-over-year to a record $436.9 million, and diluted EPS of $1.17 Q1 operating income up 59.2% year-over-year to $98.2 million or operating margin of 22.5% Q1 total Invisalign case shipments up 30 [...]

Align Technology to Introduce Two New iTero Scanners Featuring Greater Power and Portability

25/04/2018 - 22:00

Next-Generation iTero Element® 2 and New iTero Element Flex Expand iTero’s Leading Product Portfolio with More Choices and Streamlined Workflows for Every Type of Practice SAN JOSE, Calif., April 25, 2018 (GLOBE [...]

Align Introduces New Invisalign Go Clear Aligner System Integrated With iTero Scanner for Mild to Moderate Cases

25/04/2018 - 22:00

More Intuitive Invisalign Clear Aligner Treatment Designed for Everyday Dentistry SAN JOSE, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN ) today announced a new Invisalign Go product [...]

Align Technology Provides Update Regarding SmileDirectClub (SDC) Dispute

25/04/2018 - 22:00

SAN JOSE, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN ) today provided an update to its February 28, 2018 disclosure regarding SDC Financial LLC and SmileDirectClub LLC’s ( [...]

Align Technology Announces China Food and Drug Administration Approval for the iTero Element Intraoral Scanner

25/04/2018 - 22:00

SAN JOSE, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN ) today announced that the company has received approval from the China Food and Drug Administration (CFDA) to market the iTero [...]

NewLink Genetics Announces Presentation of Abstracts at ASCO 2018 Annual Meeting

25/04/2018 - 21:55

AMES, Iowa, April 25, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) today reported that two abstracts pertaining to the company's indoximod program will be presented at the American Society of [...]

Tergus Announces Key Leadership Changes

25/04/2018 - 21:12

DURHAM, N.C., April 25, 2018 (GLOBE NEWSWIRE) -- Tergus today announced key leadership changes to improve performance and accelerate growth. A key component of this stage in Tergus’ expansion is the infusion of new [...]

LIDDS: Presenterar Årsredovisning 2017

25/04/2018 - 20:34

För mer information, vänligen kontakta: Monica Wallter, CEO, +46 (0)737 07 09 22, monica.wallter@liddspharma.com Bengt Norvik, CFO, +46 (0)730 74 68 00, bengt.norvik@liddspharma.com LIDDS utvecklar effektiva läkemedel [...]

Sharecare to be featured during three sessions at HLTH in Las Vegas

25/04/2018 - 20:20

Company's co-founder and CEO Jeff Arnold and Blue Zones founder Dan Buettner to speak during general session on Monday, May 7 ATLANTA, April 25, 2018 (GLOBE NEWSWIRE) -- Sharecare, the digital health company helping [...]

Portola Pharmaceuticals to Present New Interim Phase 2 Data for Cerdulatinib at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

25/04/2018 - 19:06

– Novel Oral SYK/JAK Inhibitor for Relapsed/Refractory B-cell and T-cell Cancers – SOUTH SAN FRANCISCO, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA ) today announced that new [...]

Decisions of the Annual General Meeting of Biohit Oyj

25/04/2018 - 19:00

Biohit Oyj Decisions of the Annual General Meeting April 25, 2018 at 8:00 pm local time (EEST) The Annual General Meeting (AGM) of Biohit Oyj held on Wednesday April 25, 2018 adopted the financial statements of the [...]

Aixplorer Mach 30 SuperSonic Imagine Pushes the Boundaries of Ultrasound Imaging

25/04/2018 - 19:00

With its sleek, functional design, new user experience and greater simplicity, the new SuperSonic Imagine’s ultrasound platform integrates the unique technological innovations such as the SonicPad and increased [...]